Top Institutions in Ophthalmology, Retinal Vascular Disease, Pharmacology
Institutions were ranked based on their known leadership in ophthalmic clinical trials, translational research in retinal vascular diseases, and pioneering work in novel drug delivery systems and pharmacologic innovation, particularly in anti-VEGF and TKI therapies.
-
#1
Bascom Palmer Eye Institute
Miami, FL
Bascom Palmer is internationally recognized for its leadership in retinal disease research and clinical trials, including pioneering work in anti-VEGF therapies and novel drug delivery systems for retinal vascular conditions.
-
#2
Massachusetts Eye and Ear Infirmary
Boston, MA
Massachusetts Eye and Ear has a robust research portfolio in retinal vascular diseases and is a leader in early-phase clinical trials of novel agents including TKIs and sustained-release drug delivery platforms.
-
#3
Johns Hopkins Wilmer Eye Institute
Baltimore, MD
Wilmer Eye Institute is renowned for its comprehensive retinal disease research and clinical innovation, including studies on novel pharmacologic agents and drug delivery methods for retinal vascular disorders.
-
#4
University of California, San Francisco (UCSF) Department of Ophthalmology
San Francisco, CA
UCSF is a leader in translational research and clinical trials for retinal diseases, with a focus on innovative therapies including TKIs and novel sustained-release drug delivery systems.
-
#5
Moorfields Eye Hospital
London, N/A
Moorfields is a global leader in ophthalmic research and clinical trials, with significant contributions to the development and evaluation of anti-VEGF agents and emerging therapies such as TKIs for retinal vascular diseases.